Literature DB >> 14965391

Bacterial vaginosis and preterm birth: a prospective community-based cohort study.

Pippa Oakeshott1, Sally Kerry, Sima Hay, Philip Hay.   

Abstract

BACKGROUND: Preterm birth before 37 weeks' gestation is associated with 70% of perinatal morbidity and nearly half of long-term neurological morbidity. Hospital-based studies have shown that bacterial vaginosis is associated with preterm birth. AIM: To estimate the relative risk of preterm birth in women with and without bacterial vaginosis, detected by self-administered vaginal swab at < 10 weeks' gestation.
DESIGN: Prospective cohort study.
SETTING: Thirty-two general practices and five family planning clinics in South London. PARTICIPANTS: A total of 1216 women with bacterial vaginosis status established before 10 weeks' gestation, by analysis of Gram stained vaginal smears by two independent observers.
METHOD: All women who did not miscarry or have a termination of pregnancy before 16 weeks' gestation were sent a brief confidential questionnaire at 16 weeks and at term asking about pregnancy outcome. Data on non-responders were obtained by searches of hospital and general practice records and by telephone calls to patients.
RESULTS: Ascertainment was 87% (937/1072). The mean age of the women was 31 years. Thirteen per cent (122/925) had bacterial vaginosis and 5% (44/897) had a spontaneous preterm birth. The relative risk (RR) of preterm birth in women with bacterial vaginosis was 0.9 (95% confidence interval [CI] = 0.4 to 2.2). However, bacterial vaginosis was associated with late miscarriage at 13-23 weeks (R = 4.0, 95%CI = 1.3 to 12.1). Preterm birth was not associated with previous preterm birth, black ethnicity, age < 20 years, low social class, single marital status, or chlamydial infection. However, it was more common in women who reported smoking in pregnancy (RR = 2.9, 95% CI = 1.5 to 5.5). Of 867 responders, 552 (64%) said that providing a vaginal swab was at least as easy as providing a urine specimen.
CONCLUSIONS: In this low-risk community-based cohort, bacterial vaginosis was not a strong risk factor for preterm birth.

Entities:  

Mesh:

Year:  2004        PMID: 14965391      PMCID: PMC1314805     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  14 in total

1.  Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group.

Authors:  S L Kenyon; D J Taylor; W Tarnow-Mordi
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

Review 2.  Intrauterine infection and preterm delivery.

Authors:  R L Goldenberg; J C Hauth; W W Andrews
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

3.  Antibiotics for the prevention of preterm birth.

Authors:  R F Lamont
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

Review 4.  Preterm delivery.

Authors:  Michael M Slattery; John J Morrison
Journal:  Lancet       Date:  2002-11-09       Impact factor: 79.321

5.  Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study.

Authors:  Pippa Oakeshott; Phillip Hay; Sima Hay; Frances Steinke; Elizabeth Rink; Sally Kerry
Journal:  BMJ       Date:  2002-12-07

6.  Detection of Chlamydia trachomatis infection in early pregnancy using self-administered vaginal swabs and first pass urines: a cross-sectional community-based survey.

Authors:  Pippa Oakeshott; Phillip Hay; Sima Hay; Frances Steinke; Elizabeth Rink; Brenda Thomas; Penny Oakeley; Sally Kerry
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

7.  Infection and preterm delivery.

Authors:  P Brocklehurst
Journal:  BMJ       Date:  1999-02-27

8.  Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  J C Carey; M A Klebanoff; J C Hauth; S L Hillier; E A Thom; J M Ernest; R P Heine; R P Nugent; M L Fischer; K J Leveno; R Wapner; M Varner
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

9.  Bacterial vaginosis in early pregnancy and pregnancy outcome.

Authors:  T Kurki; A Sivonen; O V Renkonen; E Savia; O Ylikorkala
Journal:  Obstet Gynecol       Date:  1992-08       Impact factor: 7.661

10.  Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial.

Authors:  Austin Ugwumadu; Isaac Manyonda; Fiona Reid; Phillip Hay
Journal:  Lancet       Date:  2003-03-22       Impact factor: 79.321

View more
  9 in total

1.  Bacterial vaginosis: not a risk factor for preterm birth?

Authors:  Hans Verstraelen; Stijn Vansteelandt; Marleen Temmerman
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

2.  Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis.

Authors:  Katia Sutyak Noll; Patrick J Sinko; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

3.  Lactocin 160, a Bacteriocin Produced by Vaginal Lactobacillus rhamnosus, Targets Cytoplasmic Membranes of the Vaginal Pathogen, Gardnerella vaginalis.

Authors:  Yevgeniy Turovskiy; Richard D Ludescher; Alla A Aroutcheva; Sebastian Faro; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2009-01-20       Impact factor: 4.609

4.  Vaginal symptoms and bacterial vaginosis (BV): how useful is self-report? Development of a screening tool for predicting BV status.

Authors:  D B Nelson; S Bellamy; A Odibo; I Nachamkin; R B Ness; L Allen-Taylor
Journal:  Epidemiol Infect       Date:  2007-02-05       Impact factor: 2.451

Review 5.  The aetiology of bacterial vaginosis.

Authors:  Y Turovskiy; K Sutyak Noll; M L Chikindas
Journal:  J Appl Microbiol       Date:  2011-03-14       Impact factor: 3.772

6.  The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.

Authors:  Katia Sutyak Noll; Mark N Prichard; Arkady Khaykin; Patrick J Sinko; Michael L Chikindas
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

7.  Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester.

Authors:  Yevgeniy Turovskiy; Thomson Cheryian; Ammar Algburi; Ruth E Wirawan; Paul Takhistov; Patrick J Sinko; Michael L Chikindas
Journal:  Infect Dis Obstet Gynecol       Date:  2012-09-17

8.  Chlamydia related bacteria (Chlamydiales) in early pregnancy: community-based cohort study.

Authors:  F Reid; P Oakeshott; S R Kerry; P E Hay; J S Jensen
Journal:  Clin Microbiol Infect       Date:  2016-10-20       Impact factor: 8.067

9.  Association between preterm delivery and bacterial vaginosis with or without treatment.

Authors:  Masao Shimaoka; Yoshie Yo; Kunihiko Doh; Yasushi Kotani; Ayako Suzuki; Isao Tsuji; Masaki Mandai; Noriomi Matsumura
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.